Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms
Cancers · 20.06.2024 · 16 (12) · 2288
DOI: 10.3390/cancers16122288 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.06.2024. Verfasst von Anna Markowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology and Women's Health, Poznań University of Medical Sciences, 60-535 Poznań, Poland. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy is one of the leading cancer treatments. Unfortunately, its use can contribute to several side effects, including gynotoxic effects in women. Ovarian reserve suppression and estrogen deficiency result in reduced quality of life for cancer patients and are frequently the cause of infertility and early menopause. Classic alkylating cytostatics are among the most toxic chemotherapeutics in this regard. They cause DNA damage in ovarian follicles and the cells they contain, and they can also induce oxidative stress or affect numerous signaling pathways. In vitro tests, animal models, and a few studies among women have investigated the effects of various agents on the protection of the ovarian reserve during classic chemotherapy. In this review article, we focused on the possible beneficial effects of selected hormones (anti-Müllerian hormone, ghrelin, luteinizing hormone, melatonin), agents affecting the activity of apoptotic pathways and modulating gene expression (C1P, S1P, microRNA), and several natural (quercetin, rapamycin, resveratrol) and synthetic compounds (bortezomib, dexrazoxane, goserelin, gonadoliberin analogs, imatinib, metformin, tamoxifen) in preventing gynotoxic effects induced by commonly used cytostatics. The presented line of research appears to provide a promising strategy for protecting and/or improving the ovarian reserve in the studied group of cancer patients. However, well-designed clinical trials are needed to unequivocally assess the effects of these agents on improving hormonal function and fertility in women treated with ovotoxic anticancer drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Perinatology and Women's Health, Poznań University of Medical Sciences, 60-535 Poznań, Poland.
- Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, 61-614 Poznań, Poland.
- Gynecological Oncology Center, Poznańska 58A, 60-850 Poznań, Poland.
ORCID-Profile: Anna Markowska, Michał Antoszczak, Adam Huczyński
Zitieren
APA
Markowska, A., Antoszczak, M., Markowska, J., & Huczyński, A. (2024). Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms. Cancers, 16(12), 2288. https://doi.org/10.3390/cancers16122288
Vancouver
Markowska A, Antoszczak M, Markowska J, Huczyński A. Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms. Cancers. 2024;16(12):2288. doi:10.3390/cancers16122288
BibTeX
@article{Markowska2024,
author = {Markowska, Anna and Antoszczak, Michał and Markowska, Janina and Huczyński, Adam},
title = {Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms},
journal = {Cancers},
year = {2024},
volume = {16},
number = {12},
pages = {2288},
doi = {10.3390/cancers16122288}
}
EUVIMED